Human FPR2/ALX (extracellular) Blocking Peptide (#BLP-FR002) is the original antigen used for immunization during Anti-Human FPR2/ALX (extracellular) Antibody (#AFR-002) generation. The blocking peptide binds and ‘blocks’ Anti-Human FPR2/ALX (extracellular) primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.
- Western blot analysis of Human HL-60 promyelocytic leukemia (lanes 1 and 3) and K562 chronic myelogenous leukemia (lanes 2 and 4) cell lysates:
- Human minor salivary glands (1:200) (Nelson, J.W. et al. (2014) Am. J. Physiol. 306, C178.).
- (C)GGTPEERLKVAIT, corresponding to amino acid residues 184-196 of human FPR2/ALX (Accession P25090).